Larimar Therapeutics, Inc. Common Stock (NASDAQ: LRMR) last traded at $2.67, down 1.11% on the session. The quote above updates while this page is open; the figures below are drawn from Larimar Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Larimar Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker LRMR. Its market capitalisation is $277.37 million.
Valuation measures for Larimar Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $277.37M |
|---|---|
| Enterprise value | $222.60M |
| Price / book | 2.18 |
| Beta | 1.58 |
Trailing-twelve-month figures tagged in Larimar Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$172.60M |
| EPS (TTM) | -$1.95 |
|---|
| Return on equity | -135.50% |
|---|
| Cash | $92.69M |
|---|
Range and volume for LRMR over the past 52 weeks.
| 52-week high | $6.42 |
|---|---|
| 52-week low | $2.61 |
| Volume | 868.9K |
| Average volume | 1.26M |
| Previous close | $2.70 |
Invest a chosen dollar amount in Larimar Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LRMR.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.